By Fred Schulte and Lauren Weber   Health insurers that treat millions of seniors have overcharged Medicare by nearly $30 billion the past three years alone, but federal officials say they are moving ahead with long-delayed plans to recoup at least part of the money. Officials have known for years

[/infobox]   A new KFF analysis estimates that the Affordable Care Act’s tax on high-cost health plans would affect one in five (21 percent) employers offering health benefits when it takes effect in 2022 unless employers change their health plans. An even larger share (31 percent) could be affected when workers’ voluntary

    Amsterdam-based Royal Philips sold its Andover, Mass.-based healthcare headquarters to Atlantic Management Corp. May 4 in a deal worth $36 million. Royal Philips has been transferring its 1,900 employees to facilities in Cambridge, Massachusetts, and Nashville, Tennessee, since January. Atlantic Management, which paid $36 million for the facility,

AngioDynamics Inc., a provider of innovative, minimally invasive medical devices for oncology, vascular access and peripheral vascular disease, has agreed to sell its NAMIC fluid management portfolio to Medline Industries Inc. for $167.5 million, subject to customary closing conditions including antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The

  Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR). The data, which was presented at the Charing Cross

As a hedge against the 2023 expiration of its U.S. patents that protect its blockbuster drug, Humira, AbbVie Inc. will acquire Dublin, Ireland-based Allergan for $63 billion in cash and stock.     Humira sales account for more than 60 percent of AbbVie’s revenue, but biosimilar drugs approved in Europe

The Centers for Medicare & Medicaid Services (CMS) issued guidance to state Medicaid agencies June 21 that outlines the necessary assurances that states should make to ensure that program resources are reserved for those who meet eligibility requirements. This guidance follows a series of steps that CMS has taken since

  Vein Centers of America (VSA) is celebrating its 17th anniversary by offering a complimentary phone consultation with President and CEO David Schmiege.              in vein-specific practice management, marketing and revenue cycle management initiatives nationwide. “We have the experience, flexibility, structure and size to implement results quickly and to create the culture

            Connecticut-based Butterfly Network, already selling in the United States, has won the CE Mark and is releasing its single-probe, hand-held, full-body Butterfly iQ portable ultrasound system in Europe. The product consists of a transducer that plugs right into an iPhone or iPad via the Lightning port, and uses a

              BIOTRONIK is releasing in the United States its PK Papyrus-covered coronary stent, the first new device in many years to be used as an emergency therapy for acute coronary perforations. Because so few of these are expected to be used, but are expected to save many lives, the FDA